Sun Pharma rallies 4% on licensing agreement

19 août 2019
Collaboration with CMS now covers eight generic products including these seven products.
 Site référencé:  The Economic Times

The Economic Times 

Ambuja Cements Q4 results : Profit up 6% YoY to Rs 532 cr ; co approves Rs 2 dividend
1er/05/2024
Coal India Q4 Preview : Net profit seen falling QoQ ; strong operational show expected
1er/05/2024
Godrej conglomerate split : How should investors play the listed entities ?
1er/05/2024
Thinking of creating wealth with Birlas ? Here’s how group stocks fared
1er/05/2024
Q4 results today : Ambuja Cements, Adani Wilmar among 18 companies to announce earnings
1er/05/2024
Fed meeting outcome today : How it may impact Indian stock market
1er/05/2024